What We Offer?
Successful development of a biopharmaceutical or biologic drug depends on ensuring
the safety, efficacy, quality, purity, and potency of your
biopharmaceutical product. We support
comprehensive and biopharmaceutical analysis services tailored for research
In line with the ICH Q6B Guidance, Creative Proteomics offers protein analysis and characterization services including structure analysis, physicochemical properties, biological activity, immunochemical properties, and purity and impurities determination to ensure the quality and consistency of your product.Learn More
PEGylation is a process of attaching one or more molecules of polyethylene glycol (PEG) to target biomolecules including peptides, proteins, and oligonucleotides. Scientists from Creative Proteomics are professional and experienced in PEGylation and provide efﬁcient services that meet the requirements of FDA and ICH guidelines.
We can provide services to test the physical, chemical and structural characteristics, purity, impurities, and contents of antibody-drug conjugates strictly following various quality standards.
We use advanced high-performance liquid chromatography, mass spectrometry, and bioinformatics platforms to support the veriﬁcation of each bsAb product.
We can comprehensively determine the primary structure, high-level structure, post-translational modiﬁcation, and heterogeneity of Monoclonal Antibodies.
Our integrated biopharmaceutical characterization solution makes it possible to efﬁciently and accurately analyze fusion proteins for every study and ensure consistently reliable results, every time.
Our analytical scientists are highly experienced and knowledgeable in comprehensively characterizing vaccines.